InvestorsHub Logo
Followers 52
Posts 1007
Boards Moderated 0
Alias Born 07/20/2018

Re: None

Thursday, 01/10/2019 2:52:19 PM

Thursday, January 10, 2019 2:52:19 PM

Post# of 147025
This is a Section 363 sale

There is a asset sale and a stock sale

Bioamber sold there assets at a loss so that LCY/Visolis can use that and all existing NOLS in the future

They needed the Assets sold in 2018 so they could take advantage of the losses immediately following the stock purchase

Bioamber was approached before filing for CCAA and bankruptcy that LCY and Visolis was going to purchase them

Bioamber was lucky they were able to mask the entire sale by going through CCAA proceedings and not having to be as transparent as us proceedings rule

They needed to file for bankruptcy so that LCY and Visolis could acquire the contracts that would not normally be transferable in a sale during the company normal operations

They have Laura Davis Jones who is ranked the in the top restructuring lawyers in the USA working on this case along with Pricecooperwaterhouse who was chosen to represent bioamber prior to bankruptcy filing

I hope noone sold there shares knowing the true value of this company and the common shares

BTW since the Visolis transaction for the assets did not provide more value then the liens on the assets as per section 363 of the bankruptcy code "THE LAW", they have to take over the existing debt. they are okay with this because they bought THE WHOLE COMPANY















Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.